M383-2031 Screening compound: prop-2-en-1-yl 2-(2H-1,3-benzodioxole-5-carbonyl)-8-methyl-1H,2H,3H,4H-benzo[b]1,6-naphthyridine-10-carboxylate

M383-2031 Screening compound: prop-2-en-1-yl 2-(2H-1,3-benzodioxole-5-carbonyl)-8-methyl-1H,2H,3H,4H-benzo[b]1,6-naphthyridine-10-carboxylate
M383-2031 Screening compound: prop-2-en-1-yl 2-(2H-1,3-benzodioxole-5-carbonyl)-8-methyl-1H,2H,3H,4H-benzo[b]1,6-naphthyridine-10-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound M383-2031
prop-2-en-1-yl 2-(2H-1,3-benzodioxole-5-carbonyl)-8-methyl-1H,2H,3H,4H-benzo[b]1,6-naphthyridine-10-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M383-2031

Molecular Formula

C25H22N2O5 (C25 H22 N2 O5)

Compound Name

prop-2-en-1-yl 2-(2H-1,3-benzodioxole-5-carbonyl)-8-methyl-1H,2H,3H,4H-benzo[b]1,6-naphthyridine-10-carboxylate

IUPAC name

prop-2-en-1-yl 2-(2H-13-benzodioxole-5-carbonyl)-8-methyl-1H2H3H4H-benzo[b]16-naphthyridine-10-carboxylate

SMILES

Cc1ccc2nc(CCN(C3)C(c(cc4)cc5c4OCO5)=O)c3c(C(OCC=C)=O)c2c1

InChI

InChI=1S/C25H22N2O5/c1-3-10-30-25(29)23-17-11-15(2)4-6-19(17)26-20-8-9-27(13-18(20)23)24(28)16-5-7-21-22(12-16)32-14-31-21/h3-7,11-12H,1,8-10,13-14H2,2H3

InChI Key

OZPGVYCHEUIMLX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27539941

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.46

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.805

Distribution Coefficient, logD

3.805

Water Solubility, LogSw

-4.34

Polar Surface Area

64.543

Acid Dissociation Constant (pKa)

20.29

Base Dissociation Constant (pKb)

3.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

M383-2031 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with M383-2031 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M383-2031?
Check Price and Availability of M383-2031, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M383-2031 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M383-2031
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M383-2031
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M383-2031 available by request